Efficacy of vitamin E in children with immunotolerant-phase chronic hepatitis B infection

Pediatrics International

Volumn 49, Issue 5, 2007, Pages 603-607

  Dikici, Bunyamin ^a   Dagli, Abdullah ^b   Ucmak, Hasan ^c   Bilici, Meki ^d   Ece, Aydin ^b  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b DICLE UNIVERSITY   (Turkey)

^c KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

^d KAFKAS UNIVERSITY   (Turkey)

Author keywords

Children; Chronic hepatitis B; Immunotolerant phase; Therapy; Vitamin E

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; DNA; HEPATITIS B ANTIBODY; HEPATITIS B ANTIGEN;

ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOLOGICAL TOLERANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SEROLOGY; TREATMENT DURATION; VIRUS LOAD;

ALANINE TRANSAMINASE; CHILD; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNE TOLERANCE; MALE; VIRAL LOAD; VITAMIN E;

EID: 34548670512     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2007.02419.x     Document Type: Article

References (30)

1. Hilleman MR. Critical overview and outlook: Pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus. Vaccine 2003 21 : 4626 49.
2. Couillin I, Pol S, Mancini M et al. Specific vaccine therapy in chronic hepatitis B: Induction of T cell proliferative responses specific for envelope antigens. J. Infect. Dis. 1999 180 : 15 26.
3. Mahoney FJ. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin. Microbiol. Rev. 1999 12 : 351 66.
4. Sette AD, Oseroff C, Sidney J et al. Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice. J. Immunol. 2001 166 : 1389 97.
5. Hom X, Little NR, Gardner SD, Jonas MM. Predictors of virologic response to Lamivudine treatment in children with chronic hepatitis B infection. Pediatr. Infect. Dis. J. 2004 23 : 441 5.
6. Boni C, Bertoletti A, Penna A et al. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J. Clin. Invest. 1998 102 : 968 75.
7. Akbar SM, Furukawa S, Horiike N, Onji M. Vaccine therapy for hepatitis B virus carrier. Curr. Drug Targets Infect. Disord. 2004 4 : 93 101.
8. Meydani M Vitamin E. Lancet 1995 345 : 170 75.
9. Gogu SR, Bloomberg JB. Vitamin E increases interleukin2 dependent cellular growth and glycoprotein glycosylation in murine cytotoxic T-cell line. Biochem. Biophys. Res. Commun. 1993 193 : 872 7.
10. Andreone P, Gramenzi A, Bernardi M. Vitamin E for chronic hepatitis B. Ann. Intern. Med. 1998 128 : 156 7.
11. Andreone P, Fiorino S, Cursaro C et al. Vitamin E as treatment for chronic hepatitis B: Results of a randomized controlled pilot trial. Antiviral Res. 2001 49 : 75 81.
12. Dikici B, Bosnak M, Kara IH et al. Lamivudine and interferon-alpha combination treatment of childhood patients with chronic hepatitis B infection. Pediatr. Infect. Dis. J. 2001 20 : 988 92.
13. Dikici B, Bosnak M, Bosnak V et al. Combination therapy for children with chronic hepatitis B virus infection. J. Gastroenterol. Hepatol. 2002 17 : 1087 91.
14. Brook MG, Karayiannis P, Thomas HC. Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors. Hepatology 1989 10 : 761 3.
15. Bertoletti A, Chisari FV, Penna A et al. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. J. Virol. 1993 67 : 2376 80.
16. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999 284 : 825 9.
17. Meydani SN, Barklund MP, Liu S et al. Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am. J. Clin. Nutr. 1990 52 : 557 63.
18. Wang Y, Huang DS, Liang B, Watson RR. Nutritional status and immune responses in mice with murine AIDS are normalized by vitamin E supplementation. J. Nutr. 1994 124 : 2024 32.
19. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994 76 : 241 51.
20. Bertoletti A, D'Elios MM, Boni C et al. Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 1997 112 : 193 9.
21. Reizis AR, Malinovskaia VV, Shekhade S et al. Effectiveness of using recombinant interferon alfa2 (reaferon) combined with antioxidants in children with acute hepatitis B. Pediatriia 1992 3 : 60 64.
22. von Herbay A, Stahl W, Niederau C, von Laar J, Strohmeyer G, Sies H. Diminished plasma levels of vitamin E in patients with severe viral hepatitis. Free Radic. Res. 1996 25 : 461 6.
23. Uchaikin V, Cherednichenko T, Malinovskaya V et al. Use of recombinant alpha-2b-interferon in combination with antioxidants in the form of rectal suppositories (viferon) in children with chronic hepatities B and C. Acta Virol. 2000 44 : 79 83.
24. Braden GL. Treatment of Hepatitis B Accessed 2002.) Available from URL : http://www.medscape.com/viewarticle/434534
25. Pol S, Couillin I, Michel ML et al. Immunotherapy of chronic hepatitis B by anti HBV vaccine. Acta Gastroenterol. Belg. 1998 61 : 228 33.
26. Ames BN. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 1983 221 : 1256 64.
27. Singh VN, Gaby SK. Premalignant lesions: Role of antioxidant vitamins and beta-carotene in risk reduction and prevention of malignant transformation. Am. J. Clin. Nutr. 1991 53 : 386S 90S.
28. Duthie SJ, Ma A, Ross MA et al. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res. 1996 56 : 1291 5.
29. Yogeeswaran G, Mbawuike IN. Altered metabolism and cell surface expression of glycosphingolipids caused by vitamin E in cultured urine (K3T3) reticulum sarcoma cells. Lipids 1986 21 : 643 7.
30. Meydani M, Meisler JG. A closer look at vitamin E. Can this antioxidant prevent chronic diseases? Postgrad. Med. 1997 102 : 199 201.